Novo Nordisk first out of the gate with oral weight-loss drug, and its stock jumps

Relief rally underway in Novo Nordisk after a difficult year for the stock which saw it lose ground to arch-competitor Eli Lilly.

Previous Article

‘You need a third job or a rich husband’: I fell victim to Allen Stanford’s multibillion-dollar Ponzi scheme and survived

Next Article

Germany's Debt-Fueled Illusions: Merz Humiliated, Economy In Freefall

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

55 − = 51
Powered by MathCaptcha

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨